
(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Heat Wave Fuels Massive Wildfire In Australia - 2
Find Successful Magnificence Items for Sparkling Skin - 3
Several Israelis attempt to cross into Gaza, escorted back to Israel by IDF - 4
She was the ultimate '90s fitness influencer. Now she's delivering Uber Eats — and rebuilding her life. - 5
Spotify Wrapped and Apple Music Replay are here: Top songs, albums and artists of 2025
5 Morning Schedules That Stimulate Your Day
Vote in favor of your Number one method for commending a birthday
Sound and Delightful: 12 Nutritious Smoothie Recipes
Ariana Grande says Eternal Sunshine 2026 tour will be her last for a 'long, long time': 'One last hurrah'
Find the Techniques for Powerful Review Propensities: Opening Your Scholarly Potential
Book excerpt: "Eat Your Ice Cream" by Ezekiel J. Emanuel, M.D.
The most effective method to Help a Friend or family member Determined to have Cellular breakdown in the lungs
Kremlin: Russian troops conquer Pokrovsk after year of intense combat
New Jordan security fence could be done in early 2028











